This meta- analysis demonstrated that resveratrol supplementation among patients with MetS and related disorders  significantly reduced total cholesterol and increased GGT concentrations , but did not affect triglycerides , LDL- , HDL-cholesterol , ALT , and AST concentrations .
This data suggests that resveratrol may have a potential cardio-protective effect in patients with MetS and related disorders
There are current trials investigating the effect of resveratrol supplementation on lipid profiles and liver enzymes among patients with metabolic syndrome ( MetS ) and related disorders ; however , their findings are controversial .
This systematic review and meta- analysis were aim ed to determine the effects of resveratrol supplementation on lipid profiles and liver enzymes among patients with MetS and related disorders .
Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study.
BACKGROUND Case-control studies have reported that patients with ischemic heart disease ( IHD ) have a higher proportion of small , dense LDL particles than do healthy control subjects . The extent to which the risk attributed to small LDL particles may be independent of concomitant variations in plasma lipoprotein-lipid concentrations remains to be clearly determined , however , particularly through prospect i ve studies . METHODS AND RESULTS Baseline characteristics were obtained in 2103 men initially free of IHD , among whom 114 developed IHD during a 5-year follow-up period . These 114 case patients were matched with healthy control subjects for age , body mass index , smoking habits , and alcohol intake . LDL peak particle diameter ( PPD ) was measured a posteriori in 103 case-control pairs by nondenaturing gradient gel electrophoresis of whole plasma . Conditional logistic regression analysis of the case-control status revealed that men in the first tertile of the control LDL-PPD distribution ( LDL-PPD < or = 25.64 nm ) had a 3.6-fold increase in the risk of IHD ( 95 % CI , 1.5 to 8.8 ) compared with those in the third tertile ( LDL-PPD > 26.05 nm ) . Statistical adjustment for concomitant variations in LDL cholesterol , triglycerides , HDL cholesterol , and apolipoprotein B concentrations had virtually no impact on the relationship between small LDL particles and the risk of IHD . CONCLUSIONS These results represent the first prospect i ve evidence suggesting that the presence of small , dense LDL particles may be associated with an increased risk of subsequently developing IHD in men . Results also suggest that the risk attributed to small LDL particles may be partly independent of the concomitant variation in plasma lipoprotein-lipid concentrations
This meta- analysis demonstrated that resveratrol supplementation among patients with MetS and related disorders  significantly reduced total cholesterol and increased GGT concentrations , but did not affect triglycerides , LDL- , HDL-cholesterol , ALT , and AST concentrations .
This data suggests that resveratrol may have a potential cardio-protective effect in patients with MetS and related disorders
There are current trials investigating the effect of resveratrol supplementation on lipid profiles and liver enzymes among patients with metabolic syndrome ( MetS ) and related disorders ; however , their findings are controversial .
This systematic review and meta- analysis were aim ed to determine the effects of resveratrol supplementation on lipid profiles and liver enzymes among patients with MetS and related disorders .